All lobbying filings
BGR GOVERNMENT AFFAIRS
Lobbying for ALLIANCE FOR REGENERATIVE MEDICINE · Advocacy organization supporting advances in regenerative medicine
Filing
1st Quarter - Amendment
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
9
-
BRENT ALAN DEL MONTEPreviously held: Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
-
ROBB WALTONPreviously held: Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
-
JOHN STONEPreviously held: Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
-
DANIEL FARMERPreviously held: Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space
-
REMY LEIGH BRIM MASONPreviously held: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
-
JOEL D. BAILEYPreviously held: COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall
-
MARVIN BENITO FIGUEROAPreviously held: COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White House
-
RAGHAV AGGARWALPreviously held: Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior
-
CHRIS KELLYPreviously held: Health Policy Dir., Leg. Asst., Leg. Corr., Front Office Coordinator, Staff Asst. Sen. Blackburn
Government bodies contacted
4
Lobbying activity
1
Provide strategic guidance and advocacy on issues related to regulation of, access to, and reimbursement for regenerative medicine products, and any other issues related to the Alliance for Regenerative Medicine specifically.